Louisiana State Employees Retirement System acquired a new stake in Envista Holdings Corporation (NYSE:NVST – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 47,500 shares of the company’s stock, valued at approximately $1,205,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Caitong International Asset Management Co. Ltd grew its stake in shares of Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after buying an additional 1,504 shares in the last quarter. Allworth Financial LP raised its holdings in shares of Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after buying an additional 776 shares during the period. UMB Bank n.a. lifted its position in Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after acquiring an additional 636 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after acquiring an additional 949 shares in the last quarter. Finally, IFP Advisors Inc boosted its holdings in Envista by 102.9% in the 4th quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock worth $46,000 after acquiring an additional 1,071 shares during the period.
Analysts Set New Price Targets
Several analysts have issued reports on NVST shares. Barclays lowered their price objective on shares of Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research report on Thursday, June 11th. Robert W. Baird upped their target price on shares of Envista from $30.00 to $31.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Weiss Ratings lowered shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. JPMorgan Chase & Co. lifted their price target on shares of Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Finally, Morgan Stanley boosted their price objective on shares of Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, April 24th. Six analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $28.67.
Envista Price Performance
NVST stock opened at $27.59 on Friday. The stock’s 50 day moving average is $24.86 and its two-hundred day moving average is $25.27. Envista Holdings Corporation has a 52-week low of $18.77 and a 52-week high of $30.42. The company has a market capitalization of $4.49 billion, a PE ratio of 67.28, a P/E/G ratio of 1.57 and a beta of 0.86. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47.
Envista (NYSE:NVST – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.The company had revenue of $705.50 million during the quarter, compared to analysts’ expectations of $680.03 million. During the same period in the prior year, the business posted $0.24 EPS. The business’s revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts predict that Envista Holdings Corporation will post 1.42 earnings per share for the current fiscal year.
Envista Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Further Reading
- Five stocks we like better than Envista
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
